v3.26.1
Consolidated Statements of Comprehensive Loss
₪ in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
USD ($)
$ / shares
Dec. 31, 2025
ILS (₪)
₪ / shares
Dec. 31, 2024
ILS (₪)
₪ / shares
Dec. 31, 2023
ILS (₪)
₪ / shares
Profit or loss [abstract]        
Revenues $ 2,973 ₪ 9,484 ₪ 9,661 ₪ 6,188
Revenues from settlement agreement with GEHC (*) [1] 9,574 30,540
Total revenues 12,547 40,024 9,661 6,188
Cost of revenues 1,988 6,342 6,084 3,987
Gross profit 10,559 33,682 3,577 2,201
Research and development expenses, net 5,439 17,350 20,130 31,399
Sales and marketing expenses 3,704 11,815 10,318 9,434
General and administrative expenses 5,230 16,681 15,344 16,954
Operating loss 3,814 12,164 42,215 55,586
Financial expenses 2,265 7,225 540 16,206
Financial income (1,109) (3,537) (5,963) (13,352)
Financial expenses (income), net 1,156 3,688 (5,423) 2,854
Loss before income tax 4,970 15,852 36,792 58,440
Provision (benefit) for income tax [2] 1 (56) 127
Net loss and comprehensive loss $ 4,970 ₪ 15,853 ₪ 36,736 ₪ 58,567
Loss per ordinary share - basic | (per share) $ 0.77 ₪ 2.46 ₪ 5.76 ₪ 9.12
Loss per ordinary share - diluted | (per share) $ 0.77 ₪ 2.46 ₪ 5.76 ₪ 9.12
[1] Including an amount of NIS 7.1 million (approximately $2.2 million) was recognized as revenues from the (1) cancellation of orders placed by GEHC to the Company for 15,000 units Pursuant to the Settlement Agreement and (2) due to the termination of the Component Agreement.
[2] Less than $1 thousand